Fig. 6: The protein network underlying MM drug sensitivity. | Nature Cancer

Fig. 6: The protein network underlying MM drug sensitivity.

From: Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma

Fig. 6

a, STRING-db interaction network for the proteins whose abundance in myeloma cells most strongly correlates with myeloma drug responses across all proteins and drugs. Unconnected nodes in the network are not shown for simplicity. Node color represents the Spearman’s rank correlation with bortezomib response across the discovery cohort. More details are at https://myelomics.com. b, Zoom into the network region around RPS6 and DEPTOR. Legend shows signed āˆ’log10(P) per protein, sorted by their Spearman’s rank correlation coefficients. No adjustments for multiple comparisons were made. c, Box-plots (as in Fig. 2c) showing RPS6 abundance as a function of bortezomib sensitivity (n = 76 patient samples). d, Box-plots (as in Fig. 2c) showing DEPTOR abundance as a function of bortezomib sensitivity (n = 53 patient samples). e, Zoom into the network region around EYA3. f, Box-plots (as in Fig. 2c) showing EYA3 abundance as a function of bortezomib sensitivity (n = 51 patient samples). g, Box-plots showing the percentage of γH2AX-positive myeloma cells after 24 h of DMSO or bortezomib treatment across six newly diagnosed myeloma samples (n = 6 patient samples). Box-plots as in Fig. 2c. P values shown are from a two-tailed paired Student’s t-test. h, STRING-db interaction network colored by their elotuzumab drug response associations, as in a. i, Zoom into the network region around HLA-DRB5. j, Box-plots (as in Fig. 2c) showing HLA-DRB5 abundance as a function of elotuzumab sensitivity (n = 41 patient samples). k, Box-plots (as in Fig. 2c) showing the elotuzumab-induced activated T cell interactions with myeloma cells as a function of HLA-DRB5 abundance (n = 40 patient samples). Example images on the right of the plot show an activated T cell with close contact to a myeloma cell (top) and a conventional T cell without cell–cell contact to a myeloma cell (bottom). Scale bar, 10 μm. All P values depicted on box-plots (c,d,f,g,j,k) are from unpaired two-tailed Student’s t-tests. The tests were not adjusted for multiple comparisons. All box-plots (c,d,f,g,j,k) as in Fig. 2c.

Source data

Back to article page